croaie glp 1 reviews GLP-1 for Crohn's Disease: Current Evidence and Treatment Options In the gray world of

If you're using medication such as GLP-1s, don't go at it alone

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

GLP-1 agonists such as semaglutide (marketed as Ozempic and Wegovy) have surged

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

Drugs like Ozempic and Mounjaro have made regular headlines in recent years for their ability to facilitate weight loss often dramatic weight loss